Kayıkçıoğlu, E., and A. H. . Onder. “The Pan-Immune-Inflammation-Value Predicts the Survival of Patients With Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors”. Chronicles of Precision Medical Researchers, vol. 3, no. 3, Oct. 2022, doi:10.5281/zenodo.7195780.